Click here to view the original post by Healio Ophthalmology.
In addition to our own original articles, the Retina Consultant team expertly curates relevant news and research from leading publications.to provide our readers with a comprehensive view of the retina & ophthalmology landscape, Full credit belongs to the original authors and publication.
By clicking the link above, you will be leaving our site to view an article from its original source.
Sharpen your perspective. Get our weekly analysis of the news shaping the retina industry.
When I opened my laptop this morning, up popped a message on LinkedIn: Congratulations on 21 years at Allergan!
Stopped me in my tracks, to be honest. That is as long as my practice, SkyVision Centers, has been in existence. I have been an active consultant working with the teams at Allergan (now AbbVie) for 21 years. Reading that reminded me of how foundational the diagnosis and treatment of dry eye disease (DED) have been in the development of my career as both physician and physician-consultant. The arc of my career in many ways tracks the arc of DED treatment as a subspecialty.
It seems